-
Pfizer's Vyndaqel, Vyndamax win US nod for rare disease
pharmatimes
May 09, 2019
Pfizer's Vyndaqel, Vyndamax win US nod for rare disease.
-
FDA approves novel treatments for heart disease
europeanpharmaceuticalreview
May 09, 2019
The US Food and Drug Administration (FDA) has approved new treatments for heart disease caused by ATTR-CM in adults.
-
After Concussions, Some Ex-Athletes Show Key Marker for Brain Disease: Study
drugs
May 09, 2019
After Concussions, Some Ex-Athletes Show Key Marker for Brain Disease.
-
FDA Approves New Treatments Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) for Heart Disease Caused by Transthyretin Mediated Amyloidosis
drugs
May 07, 2019
FDA Approves New Treatments Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) for Heart Disease Caused by Transthyretin Mediated Amyloidosis.
-
Non-invasive technique for probing cells may reveal disease
europeanpharmaceuticalreview
May 07, 2019
Engineers have devised a non-invasive way to assess a cell’s mechanical properties simply by observation…
-
Simple blood test may predict MRI disease activity in MS
europeanpharmaceuticalreview
May 05, 2019
A blood test to monitor a nerve protein in the blood of people with multiple sclerosis may help predict whether disease activity is flaring up…
-
Walnuts may help lower blood pressure for those at risk of heart disease
worldpharmanews
May 05, 2019
Walnuts may help lower blood pressure for those at risk of heart disease.
-
Amgen ignites a social fitness movement to support the fight against heart disease and cancer
worldpharmanews
May 05, 2019
Amgen ignites a social fitness movement to support the fight against heart disease and cancer.
-
Researchers define Alzheimer's-like brain disorder
worldpharmanews
May 05, 2019
A brain disorder that mimics symptoms of Alzheimer's disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the condition.
-
Diabetes drug significantly reverses memory loss in Alzheimer’s disease
europeanpharmaceuticalreview
April 30, 2019
A drug developed for diabetes could be used to treat Alzheimer’s after scientists discover it significantly reversed memory loss in mice through a triple method of action…